vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与Tyler Technologies（TYL）财务数据对比。点击上方公司名可切换其他公司
Tyler Technologies的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.9倍（$613.5M vs $321.1M），Tyler Technologies净利率更高（13.2% vs -18.2%，领先31.5%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 8.6%），Tyler Technologies自由现金流更多（$2.0M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
Tyler Technologies, Inc.是总部位于美国得克萨斯州普莱诺的科技企业，主营面向美国公共部门提供自研专有软件，目前在全美17个州设有办事处，另在加拿大安大略省多伦多市设有一处办公网点。
MDGL vs TYL — 直观对比
营收规模更大
TYL
是对方的1.9倍
$321.1M
营收增速更快
MDGL
高出202.2%
8.6%
净利率更高
TYL
高出31.5%
-18.2%
自由现金流更多
TYL
多$135.9M
$-133.8M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $613.5M |
| 净利润 | $-58.6M | $81.2M |
| 毛利率 | — | 48.3% |
| 营业利润率 | -18.6% | 16.3% |
| 净利率 | -18.2% | 13.2% |
| 营收同比 | 210.8% | 8.6% |
| 净利润同比 | 1.4% | — |
| 每股收益（稀释后） | $-2.55 | $1.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLTYL
| Q1 26 | — | $613.5M | ||
| Q4 25 | $321.1M | $575.2M | ||
| Q3 25 | $287.3M | $595.9M | ||
| Q2 25 | $212.8M | $596.1M | ||
| Q1 25 | $137.3M | $565.2M | ||
| Q4 24 | $103.3M | $541.1M | ||
| Q3 24 | $62.2M | $543.3M | ||
| Q2 24 | — | $541.0M |
净利润MDGLTYL
| Q1 26 | — | $81.2M | ||
| Q4 25 | $-58.6M | $65.5M | ||
| Q3 25 | $-114.2M | $84.4M | ||
| Q2 25 | $-42.3M | $84.6M | ||
| Q1 25 | $-73.2M | $81.1M | ||
| Q4 24 | $-59.4M | $65.2M | ||
| Q3 24 | $-107.0M | $75.9M | ||
| Q2 24 | — | $67.7M |
毛利率MDGLTYL
| Q1 26 | — | 48.3% | ||
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 47.2% | ||
| Q2 25 | — | 45.8% | ||
| Q1 25 | 96.7% | 47.3% | ||
| Q4 24 | — | 43.8% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 44.0% |
营业利润率MDGLTYL
| Q1 26 | — | 16.3% | ||
| Q4 25 | -18.6% | 13.0% | ||
| Q3 25 | -39.7% | 16.4% | ||
| Q2 25 | -22.2% | 16.0% | ||
| Q1 25 | -57.8% | 15.8% | ||
| Q4 24 | -64.8% | 13.2% | ||
| Q3 24 | -187.1% | 15.2% | ||
| Q2 24 | — | 14.4% |
净利率MDGLTYL
| Q1 26 | — | 13.2% | ||
| Q4 25 | -18.2% | 11.4% | ||
| Q3 25 | -39.8% | 14.2% | ||
| Q2 25 | -19.9% | 14.2% | ||
| Q1 25 | -53.4% | 14.3% | ||
| Q4 24 | -57.5% | 12.1% | ||
| Q3 24 | -172.0% | 14.0% | ||
| Q2 24 | — | 12.5% |
每股收益（稀释后）MDGLTYL
| Q1 26 | — | $1.88 | ||
| Q4 25 | $-2.55 | $1.50 | ||
| Q3 25 | $-5.08 | $1.93 | ||
| Q2 25 | $-1.90 | $1.93 | ||
| Q1 25 | $-3.32 | $1.84 | ||
| Q4 24 | $-2.50 | $1.48 | ||
| Q3 24 | $-4.92 | $1.74 | ||
| Q2 24 | — | $1.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $346.4M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $3.6B |
| 总资产 | $1.3B | $4.8B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLTYL
| Q1 26 | — | $346.4M | ||
| Q4 25 | $198.7M | $1.1B | ||
| Q3 25 | $295.7M | $950.8M | ||
| Q2 25 | $186.2M | $892.3M | ||
| Q1 25 | $183.6M | $807.4M | ||
| Q4 24 | $100.0M | $768.0M | ||
| Q3 24 | $232.7M | $544.3M | ||
| Q2 24 | — | $258.0M |
总债务MDGLTYL
| Q1 26 | — | — | ||
| Q4 25 | $339.9M | $599.7M | ||
| Q3 25 | $339.8M | $599.2M | ||
| Q2 25 | $118.4M | $598.8M | ||
| Q1 25 | $118.0M | $598.4M | ||
| Q4 24 | $117.6M | $597.9M | ||
| Q3 24 | $117.1M | $597.5M | ||
| Q2 24 | — | $597.1M |
股东权益MDGLTYL
| Q1 26 | — | $3.6B | ||
| Q4 25 | $602.7M | $3.7B | ||
| Q3 25 | $625.7M | $3.6B | ||
| Q2 25 | $696.0M | $3.6B | ||
| Q1 25 | $710.6M | $3.5B | ||
| Q4 24 | $754.4M | $3.4B | ||
| Q3 24 | $777.2M | $3.3B | ||
| Q2 24 | — | $3.1B |
总资产MDGLTYL
| Q1 26 | — | $4.8B | ||
| Q4 25 | $1.3B | $5.6B | ||
| Q3 25 | $1.4B | $5.5B | ||
| Q2 25 | $1.0B | $5.4B | ||
| Q1 25 | $996.6M | $5.2B | ||
| Q4 24 | $1.0B | $5.2B | ||
| Q3 24 | $1.1B | $5.0B | ||
| Q2 24 | — | $4.8B |
负债/权益比MDGLTYL
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | 0.16× | ||
| Q3 25 | 0.54× | 0.17× | ||
| Q2 25 | 0.17× | 0.16× | ||
| Q1 25 | 0.17× | 0.17× | ||
| Q4 24 | 0.16× | 0.18× | ||
| Q3 24 | 0.15× | 0.18× | ||
| Q2 24 | — | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $107.3M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $2.0M |
| 自由现金流率自由现金流/营收 | -41.7% | 0.3% |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 1.32× |
| 过去12个月自由现金流最近4个季度 | — | $585.7M |
8季度趋势，按日历期对齐
经营现金流MDGLTYL
| Q1 26 | — | $107.3M | ||
| Q4 25 | $-133.5M | $243.9M | ||
| Q3 25 | $79.8M | $255.2M | ||
| Q2 25 | $-47.1M | $98.3M | ||
| Q1 25 | $-88.9M | $56.2M | ||
| Q4 24 | $-104.5M | $224.8M | ||
| Q3 24 | $-67.0M | $263.7M | ||
| Q2 24 | — | $64.3M |
自由现金流MDGLTYL
| Q1 26 | — | $2.0M | ||
| Q4 25 | $-133.8M | $239.6M | ||
| Q3 25 | $79.0M | $251.3M | ||
| Q2 25 | — | $92.8M | ||
| Q1 25 | — | $53.8M | ||
| Q4 24 | $-104.7M | $221.0M | ||
| Q3 24 | $-67.8M | $260.8M | ||
| Q2 24 | — | $57.7M |
自由现金流率MDGLTYL
| Q1 26 | — | 0.3% | ||
| Q4 25 | -41.7% | 41.7% | ||
| Q3 25 | 27.5% | 42.2% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 9.5% | ||
| Q4 24 | -101.3% | 40.8% | ||
| Q3 24 | -109.0% | 48.0% | ||
| Q2 24 | — | 10.7% |
资本支出强度MDGLTYL
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.8% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.0% | 0.4% | ||
| Q4 24 | 0.2% | 0.7% | ||
| Q3 24 | 1.3% | 0.5% | ||
| Q2 24 | — | 1.2% |
现金转化率MDGLTYL
| Q1 26 | — | 1.32× | ||
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 3.02× | ||
| Q2 25 | — | 1.16× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 3.45× | ||
| Q3 24 | — | 3.47× | ||
| Q2 24 | — | 0.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
TYL
| Subscriptions | $429.7M | 70% |
| Maintenance | $108.9M | 18% |
| Other | $74.9M | 12% |
